HPV Vaccination Acceptance by African-American Parents: Identifying Psychosocial Barriers

Trial Profile

HPV Vaccination Acceptance by African-American Parents: Identifying Psychosocial Barriers

Completed
Phase of Trial: Phase II

Latest Information Update: 25 May 2015

At a glance

  • Drugs Human papillomavirus vaccine recombinant quadrivalent Merck (Primary)
  • Indications Cervical cancer; Human papillomavirus infections
  • Focus Therapeutic Use
  • Most Recent Events

    • 06 Sep 2011 Planned end date changed from 1 Mar 2010 to 1 Jan 2012 as reported by ClinicalTrials.gov.
    • 06 Sep 2011 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
    • 10 Jun 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top